Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 28

Page
per page
  1. Loratadine
    A2960 Loratadine
    Target: Histamine H1 Receptors
    Summary: Peripheral HH1R antagonist
      insoluble in H2O; ≥19.14 mg/mL
  2. Enzastaurin (LY317615)
    A1670 Enzastaurin (LY317615)
     2 Citation
    Target: PKC
    Summary: PKC beta inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
  3. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  4. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  5. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  6. Bexarotene
    A8380 Bexarotene
    Target: Retinoid X receptors (RXR)
    Summary: Retinoid Receptor agonist
      insoluble in H2O; ≥10.35 mg/mL
  7. CH5424802
    A8393 CH5424802
    Target: ALK
    Summary: ALK inhibitor,potent and ATP-competitive
  8. RGFP966
    A8803 RGFP966
     4 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Specific HDAC3 inhibitor
      insoluble in H2O; ≥18.12 mg/mL
  9. Fostamatinib (R788)
    B2284 Fostamatinib (R788)
    Target: Syk
    Summary: Spleen tyrosine kinase (Syk) inhibitor
      insoluble in H2O; ≥100.4 mg/mL
  10. Lomustine
    B1963 Lomustine
     1 Citation
    Target: RNA synthesis
    Summary: Antineoplastic drug
      insoluble in H2O; ≥23.41 mg/mL

Items 1-10 of 28

Page
per page